Member News
-
Nickel 28 Updates Dividend Policy and Debt Repayment Strategy
January 30, 2023 (Source) – Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) provides the…
-
December 2022 Quarterly Activities Report
20230130-December-Quarterly-Activities-ReportDownload
-
TrustBIX Inc. Announces Final Exchange Acceptance and Completion of Previously Announced Convertible Debenture Financing
January 27, 2023 (Source) – TrustBIX Inc. (TSXV: TBIX) (OTCQB: TBIXF) (“TrustBIX” or the “Company”) is pleased to announce receipt…
-
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares for Debt
January 27, 2023 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) announces that, further to its news release…
-
Fission 3.0 Confirms Name Change to F3 Uranium Corp.
January 27, 2023 (Source) – Fission 3.0 Corp. (TSXV: FUU) (OTCQB: FISOF) (“F3” or “the Company”) is pleased to…
-
Visionstate Announces Corporate Sponsorship of Exceed Solar by Bunzl Canada
Distribution leader sponsors Exceed Solar’s state-of-the-art, solar-powered greenhouse to fight food insecurity. January 27, 2023 (Source) – Visionstate…
-
Fission 3.0 Corp. Responds to OTC Markets Request on Recent Promotional Activity
January 26, 2023 (Source) – Fission 3.0 Corp. (TSXV: FUU) (the “Company”) announced today that it has been requested…
-
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office
January 26, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Sona Nanotech to Acquire Cancer Therapy Developer Siva Therapeutics
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
-
Valeo Pharma Announces Filing of a New Drug Submission-COVID 19 With Health Canada for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients
In the final analysis of the Phase 3 cinical study conducted by Veru Inc., sabizabulin showed a 51.6%…
